Literature DB >> 22076432

Kidney and liver transplantation in patients with autosomal recessive polycystic kidney disease: a multicentric study.

Marion Chapal1, Agnès Debout, Alexandre Dufay, Rémi Salomon, Gwenaelle Roussey, Stéphane Burtey, Emma Allain Launay, Cécile Vigneau, Gilles Blancho, Chantal Loirat, Maryvonne Hourmant, Fadi Fakhouri.   

Abstract

BACKGROUND AND OBJECTIVES: In contrast to the improvement in our understanding of the pathogenesis and presentation of autosomal recessive polycystic kidney disease (ARPKD), data regarding the issue of kidney and liver transplantation in patients with ARPKD remain particularly scarce. Here, we report the results and outcome of renal and/or liver transplantation in a series of patients with ARPKD.
METHODS: Fourteen ARPKD patients (age: 3-25 years) who underwent renal transplantation with or without liver transplantation were retrospectively identified in five French nephrology departments. The patients' medical charts were reviewed and relevant data were collected.
RESULTS: The clinical and radiological presentation of the 14 patients was highly variable illustrating the heterogeneity of ARPKD. Six patients underwent kidney and/or liver transplantation in adulthood. First renal graft survival was 92, 78 and 14% at 1, 5 and 10 years after renal transplantation, respectively. Mortality rate was relatively high (3/14; 21%) in these young patients and was directly related to infectious complications (recurrent angiocholitis) of severe Caroli's disease (dilatation of intra- and/or extra-hepatic bile ducts), a typical feature of ARPKD.
CONCLUSIONS: Our data suggest that ARPKD patients evaluated for renal transplantation should be carefully screened for severe Caroli's disease. Even though the limited number of patients included in our study precludes any definite recommendation, pre-emptive liver transplantation may be a therapeutic option in ARPKD patients with severe Caroli's disease evaluated for renal transplantation.

Entities:  

Mesh:

Year:  2011        PMID: 22076432     DOI: 10.1093/ndt/gfr588

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

Review 1.  Large-duct cholangiopathies: aetiology, diagnosis and treatment.

Authors:  Shyam Menon; Andrew Holt
Journal:  Frontline Gastroenterol       Date:  2019-01-04

Review 2.  New approaches to the autosomal recessive polycystic kidney disease patient with dual kidney-liver complications.

Authors:  Grzegorz Telega; David Cronin; Ellis D Avner
Journal:  Pediatr Transplant       Date:  2013-04-17

3.  Successful long-term outcome of pediatric liver-kidney transplantation: a single-center study.

Authors:  Jesús Quintero Bernabeu; Javier Juamperez; Marina Muñoz; Olalla Rodriguez; Ramon Vilalta; José A Molino; Marino Asensio; Itxarone Bilbao; Gema Ariceta; Carlos Rodrigo; Ramón Charco
Journal:  Pediatr Nephrol       Date:  2017-08-25       Impact factor: 3.714

Review 4.  Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects.

Authors:  Erum A Hartung; Lisa M Guay-Woodford
Journal:  Pediatrics       Date:  2014-08-11       Impact factor: 7.124

5.  MALDI imaging MS reveals candidate lipid markers of polycystic kidney disease.

Authors:  Hermelindis Ruh; Theresia Salonikios; Jens Fuchser; Matthias Schwartz; Carsten Sticht; Christina Hochheim; Bernhard Wirnitzer; Norbert Gretz; Carsten Hopf
Journal:  J Lipid Res       Date:  2013-07-12       Impact factor: 5.922

Review 6.  Polycystic kidney disease.

Authors:  Carsten Bergmann; Lisa M Guay-Woodford; Peter C Harris; Shigeo Horie; Dorien J M Peters; Vicente E Torres
Journal:  Nat Rev Dis Primers       Date:  2018-12-06       Impact factor: 52.329

Review 7.  Combined liver and kidney transplantation in children.

Authors:  Hannu Jalanko; Mikko Pakarinen
Journal:  Pediatr Nephrol       Date:  2013-05-04       Impact factor: 3.714

Review 8.  A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease.

Authors:  Claire Woon; Ashleigh Bielinski-Bradbury; Karl O'Reilly; Paul Robinson
Journal:  BMC Nephrol       Date:  2015-08-15       Impact factor: 2.388

Review 9.  Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy.

Authors:  William E Sweeney; Ellis D Avner
Journal:  Pediatr Res       Date:  2013-10-31       Impact factor: 3.756

10.  Rationale, design and objectives of ARegPKD, a European ARPKD registry study.

Authors:  Kathrin Ebner; Markus Feldkoetter; Gema Ariceta; Carsten Bergmann; Reinhard Buettner; Anke Doyon; Ali Duzova; Heike Goebel; Dieter Haffner; Barbara Hero; Bernd Hoppe; Thomas Illig; Augustina Jankauskiene; Norman Klopp; Jens König; Mieczyslaw Litwin; Djalila Mekahli; Bruno Ranchin; Anja Sander; Sara Testa; Lutz Thorsten Weber; Dorota Wicher; Ayse Yuzbasioglu; Klaus Zerres; Jörg Dötsch; Franz Schaefer; Max Christoph Liebau
Journal:  BMC Nephrol       Date:  2015-02-18       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.